SYSTEMIC LUPUS ERYTHEMATOSUS AND HYPERTENSION WITHOUT RENAL INSUFFICIENCY
Authors: A I SUTNICK, A M SELLERS, W A JEFFERS, C C WOLFERTH
Journal: Annals of Internal Medicine (1960)

Article1 April 1960SYSTEMIC LUPUS ERYTHEMATOSUS AND HYPERTENSION WITHOUT RENAL INSUFFICIENCYALTON I. SUTNICK, M.D., ALFRED M. SELLERS, M.D., WILLIAM A. JEFFERS, M.D., F.A.C.P., CHARLES C. WOLFERTH, M.D., F.A.C.P.ALTON I. SUTNICK, M.D.Search for more papers by this author, ALFRED M. SELLERS, M.D.Search for more papers by this author, WILLIAM A. JEFFERS, M.D., F.A.C.P.Search for more papers by this author, CHARLES C. WOLFERTH, M.D., F.A.C.P.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-52-4-849 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptIn the evaluation of patients with hypertension, specific etiologic factors such as coarctation of the aorta, unilateral renal disease or polycystic disease of the kidneys have been sought, but have been found only occasionally. Continuing improvements in diagnostic methods, however, have made possible the discovery of new factors operative in association with high blood pressure. Among these, we believe that systemic lupus deserves current emphasis.Since Hargraves'1description of the lupus erythematosus cell in 1948 there has been a marked rise in the reported incidence of systemic lupus erythematosus (S.L.E.), due presumably to this new diagnostic aid. A review of...Bibliography1. HargravesRichmondMorton MMHR: Presentation of two bone marrow elements: the "tart" cell and the "L.E." cell, Proc. Staff Meet., Mayo Clin. 23: 25, 1948. MedlineGoogle Scholar2. PerrySchroeder MHA: Syndrome simulating collagen disease caused by hydralazine (Apresoline), J. A. M. A. 154: 670, 1954. CrossrefMedlineGoogle Scholar3. MooreShulmanScott JELEJT: The natural history of systemic lupus erythematosus: an approach to its study through chronic biologic false positive reactors, J. Chron. Dis. 5: 282, 1957. CrossrefMedlineGoogle Scholar4. LibmanSacks EB: A hitherto undescribed form of valvular and mural endocarditis, Arch. Int. Med. 33: 701, 1924. CrossrefGoogle Scholar5. GriffithVural GCIL: Acute and subacute disseminated lupus erythematosus: a correlation of clinical and post mortem findings in eighteen cases, Circulation 3: 492, 1951. CrossrefMedlineGoogle Scholar6. JessarLamont-HaversRagan RARWC: Natural history of lupus erythematosus disseminatus, Ann. Int. Med. 38: 717, 1953. LinkGoogle Scholar7. TalbottFerrandis JHRM: Collagen diseases, 1956, Grune and Stratton, New York, p. 54. Google Scholar8. SofferBader LJR: Corticotrophin and cortisone in acute disseminated lupus erythematosus, J. A. M. A. 149: 1002, 1952. CrossrefMedlineGoogle Scholar9. Haserick JR: Modern concepts of lupus erythematosus; a review of 126 cases, J. Chron. Dis. 1: 317, 1955. CrossrefMedlineGoogle Scholar10. HarveyShulmanTumultyConleySchoenrich AMLEPACLEH: Systemic lupus erythematosus: review of the literature and clinical analysis of 138 cases, Medicine 33: 291, 1954. CrossrefMedlineGoogle Scholar11. Tumulty PA: The clinical course of systemic lupus erythematosus, J. A. M. A. 156: 947, 1954. CrossrefMedlineGoogle Scholar12. Armas-CruzHarneckerDucachJalilGonzalez RJGJF: Clinical diagnosis of systemic lupus erythematosus, Am. J. Med. 25: 409, 1958. CrossrefMedlineGoogle Scholar13. StickneyKeith JMNM: Renal involvement in disseminated lupus erythematosus, Arch. Int. Med. 66: 643, 1940. CrossrefGoogle Scholar14. Bricker N: Disseminated lupus erythematosus; clinicopathologic conference, Am. J. Med. 26: 303, 1959. CrossrefMedlineGoogle Scholar15. BaehrKlempererSchifrin GPA: A diffuse disease of the peripheral circulation (usually associated with lupus erythematosus and endocarditis), Tr. A. Am. Physicians 50: 139, 1935. Google Scholar16. Fishberg AM: Hypertension and nephritis, 1954, Lea and Febiger, Philadelphia, p. 538. Google Scholar17. CohenCadman HEF: The natural history of lupus erythematosus and its modification by cortisone and corticotropin, Lancet 2: 305, 1953. Google Scholar18. DuboisCommonsStarrSteinMorrison ELRRPCSR: Corticotropin and cortisone treatment for systemic lupus erythematosus, J. A. M. A. 149: 995, 1952. CrossrefMedlineGoogle Scholar19. Mackay IR: The clinical features, pathogenesis and therapy of systemic lupus erythematosus, M. J. Australia 2: 279, 1958. CrossrefMedlineGoogle Scholar20. SelyeSylvesterHallLeblond HOCECP: Hormonal production of arthritis, J. A. M. A. 124: 201, 1944. CrossrefGoogle Scholar21. CaugheyMcCoy JEJE: Addison's disease with associated polyarthritis: an aetiological study of the arthritis syndrome, Brit. M. J. 2: 1189, 1951. CrossrefMedlineGoogle Scholar22. Hursh LM: Arthritis following the use of desoxycorticosterone acetate and cortisone: occurrence in patient with adrenal cortical hypofunction, J. A. M. A. 157: 1005, 1955. MedlineGoogle Scholar23. SlocumbPolleyWard CHHFLE: Diagnosis, treatment and prevention of hypercortisonism in patients with rheumatoid arthritis, Proc. Staff Meet., Mayo Clin. 32: 227, 1957. MedlineGoogle Scholar24. ShearnPirofsky MAB: Disseminated lupus erythematosus, Arch. Int. Med. 90: 790, 1952. CrossrefGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: Philadelphia, Pennsylvania*Received for publication July 21, 1959.From the Edward B. Robinette Foundation, Medical Clinic, and the Surgical Service of the Hospital of the University of Pennsylvania, Philadelphia.†This work was done during the tenure of a traineeship of the National Institutes of Health.Requests for reprints should be addressed to Alfred M. Sellers, M.D., University Hospital, Thirty-sixth and Spruce Streets, Philadelphia 4, Pennsylvania. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byHypertension in Patients with Cutaneous Lupus ErythematosusHypertension artérielle maligne et lupus erythémateux disséminéZur Klinik und Prognose der Nierenmanifestationen bei Lupus erythematodesNiere bei Tumoren, Blutkrankheiten und ParaproteinämienRheumatism and Arthritis Review of American and English Literature of Recent Years (Fifteenth Rheumatism Review)CHARLEY J. SMYTH, M.D., F.A.C.P., FELIX E. DEMARTINI, M.D., F.A.C.P., EPHRAIM P. ENGLEMAN, M.D., F.A.C.P., EDWARD C. FRANKLIN, M.D., DONALD F. HILL, M.D., F.A.C.P., JOSEPH LEE HOLLANDER, M.D., F.A.C.P., HOWARD L. HOLLEY, M.D., F.A.C.P., JOHN G. MAYNE, M.D., F.A.C.P., WILLIAM M. MIKKELSEN, M.D., F.A.C.P., MAX M. MONTGOMERY, M.D., F.A.C.P., CARL M. PEARSON, M.D., F.A.C.P., CHARLES L. SHORT, M.D., F.A.C.P., HUGH A. SMYTHE, M.D., F.R.C.P. (C), OTTO STEINBROCKER, M.D.The clinical manifestations of systemic lupus erythematosus 1 April 1960Volume 52, Issue 4Page: 849-857KeywordsHypertensionKidneysLupus erythematosusMedical servicesPolycystic kidney diseasePrimary hypertensionRashesRenal diseasesResearch grantsResearch laboratories ePublished: 1 December 2008 Issue Published: 1 April 1960 PDF downloadLoading ...